Topline results from metastatic breast cancer phase 3 trial
Updated prostate cancer results show anti-tumour activity
Gesynta Pharma continues endometriosis work
First-in-human circular RNA therapy for radiation-induced xerostomia
Mironid raises $46m to advance clinical development of rare kidney disease treatment
Foundation for Angelman Syndrome Therapeutics announces agreement with Apertura Gene Therapy for access to blood-brain barrier-crossing capsid
3D genome mapping in rare immune cells reveals new Crohn’s genes
Cancer cells hijack a fatty acid to escape immune attack in liver metastases
Collaboration aims to develop new class of medicines for in vivo CAR-T
Data validates new method for single-cell transcriptomic tumour profiling from clinical pathology samples
White paper looks at early clinical development of B-cell depletion therapies in autoimmune disease
3D genome mapping in rare immune cells reveals new Crohn’s disease genes